Dr Reddys Laboratories Share Price Today - Live Blog for December 23, 2025

Dr Reddys Laboratories Ltd observed a -0.20% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,282.30. The stock has a PE ratio of 18.6000, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.20% boost, with the current market value at ₹1,284.50 per share. This surge has not gone unnoticed by investors.

After a -0.03% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,281.90. The stock has a PE ratio of 18.6000, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.01%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,283.30 per share.

Dr Reddys Laboratories Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,283.10, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's share price rallied by 0.12%, reaching the current market price of ₹1,283.20. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.07%, a situation worth noting. At present, the stock is trading at ₹1,281.65. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.6000, while the industry PE ratio is 33.3119.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.07%, with its current market value per share resting at ₹1,282.10. This development highlights the stock's appeal to investors.

Demonstrating a commendable 0.12% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,281.00. In terms of valuation, the stock maintains a PE ratio of 18.6000, while the industry PE ratio stands at 33.3119.

The share price of Dr Reddys Laboratories Ltd plunged by -0.01%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,279.65, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's share price has fallen by -0.21%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,280.70, and market participants are assessing the implications. The stock has a PE ratio of 18.6000, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.05% increase and currently trading at ₹1,282.00 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd witnessed a substantial 0.03% increase in its share price and is currently trading at ₹1,279.75. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.13% drop, and it's now trading at ₹1,279.40 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.03% recently. As of now, this stock is actively trading at a current market price of ₹1,281.05 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd stock price decreased by -0.05%, with the current market value at ₹1,281.40 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd experienced a -0.12% downturn in its share price, and it's currently trading at ₹1,282.20. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's stock has surged by 0.03%, and it is currently trading at ₹1,283.75. Additionally, the stock maintains a PE ratio of 18.6000, while the industry PE is 33.3119.

Dr Reddys Laboratories Ltd witnessed a -0.05% drop in its share price and is currently trading at ₹1,283.40. With the stock's PE at 18.6000 and the industry PE at 33.3119, investors are weighing their options.

After a notable 0.02% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,283.85. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

Dr Reddys Laboratories Ltd experienced a -0.09% downturn in its share price, and it's currently trading at ₹1,283.55. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.09%, reaching a current market price of ₹1,283.55. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has dropped by -0.09%, a development that warrants careful analysis. Presently trading at ₹1,283.55, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd experienced a -0.19% slump and is currently trading at ₹1,284.70. While the stock maintains a PE ratio of 18.6000, the industry PE is 33.3119, raising questions about valuation.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.39%, reaching the current market price of ₹1,287.30. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.00%. At this moment, it's actively trading at ₹1,282.95, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd shares saw a -0.15% decrease, reaching a current market price of ₹1,283.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.6000, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has dropped by -0.01%, a development that warrants careful analysis. Presently trading at ₹1,286.00, investors are assessing whether this presents an opportunity or a risk.